Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The survival motor neuron 1 protein (SMN1) is a highly conserved, multifunctional protein essential for motor neuron survival and function. It is a key component of the SMN complex, which plays a critical role in snRNP biogenesis and spliceosome assembly. Deficiency in SMN1 leads to spinal muscular atrophy (SMA), a severe neurodegenerative disease. Therapeutic strategies aim to increase functional SMN protein levels to mitigate the effects of SMN1 deficiency.
Currently, approved therapies aim to increase SMN protein levels through various mechanisms such as gene therapy, splicing modulation, or stabilization of the protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Survival Motor Neuron 1 Protein (SMN1).